Strategic combinatorial delivery of Tranilast and Paclitaxel using differently functionalized PLGA Nanoparticles for Enhanced penetration and Accumulation in Breast Tumor

[1]  Huanwen Tang,et al.  Cell-based carrier for targeted hitchhiking delivery , 2022, Drug Delivery and Translational Research.

[2]  Ruibing Wang,et al.  In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma , 2022, Science advances.

[3]  D. Esposito,et al.  Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination , 2021, Nature Communications.

[4]  S. Guru,et al.  Enigmatic role of exosomes in breast cancer progression and therapy. , 2021, Life sciences.

[5]  M. Nørgaard,et al.  The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis , 2021, Journal of the National Cancer Institute.

[6]  S. Patil,et al.  Angiogenesis induction in breast cancer: A paracrine paradigm , 2021, Cell biochemistry and function.

[7]  J. Garssen,et al.  Chemotherapy: a double-edged sword in cancer treatment , 2021, Cancer Immunology, Immunotherapy.

[8]  Ruibing Wang,et al.  Supramolecular Macrophage‐Liposome Marriage for Cell‐Hitchhiking Delivery and Immunotherapy of Acute Pneumonia and Melanoma , 2021, Advanced Functional Materials.

[9]  E. Bremer,et al.  The Role of Macrophages in Cancer Development and Therapy , 2021, Cancers.

[10]  James J. Lai,et al.  Immune cell shuttle for precise delivery of nanotherapeutics for heart disease and cancer , 2021, Science Advances.

[11]  K. Kataoka,et al.  Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis , 2020, Advanced science.

[12]  M. Kohandel,et al.  Effect of vascular normalization on drug delivery to different stages of tumor progression: In-silico analysis , 2020 .

[13]  K. Kataoka,et al.  TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity , 2020, Theranostics.

[14]  K. Toh,et al.  Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment. , 2019, ACS nano.

[15]  Ding Ding,et al.  Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.

[16]  Hiroshi Maeda,et al.  Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs , 2018, Clinical and Translational Medicine.

[17]  J. Condeelis,et al.  Chemotherapy-induced metastasis: mechanisms and translational opportunities , 2018, Clinical & Experimental Metastasis.

[18]  Soon-Sun Hong,et al.  Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery. , 2017, Cancer letters.

[19]  Thomas E Rohan,et al.  Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism , 2017, Science Translational Medicine.

[20]  A. Cheng,et al.  A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer , 2016, BMC Cancer.

[21]  S. Lai,et al.  Anti-PEG immunity: emergence, characteristics, and unaddressed questions. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[22]  B. Zetter,et al.  The Contribution of Angiogenesis to the Process of Metastasis. , 2015, Cancer journal.

[23]  S. Mitragotri,et al.  Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[24]  E. Rofstad,et al.  Tumor Interstitial Fluid Pressure—A Link between Tumor Hypoxia, Microvascular Density, and Lymph Node Metastasis , 2014, Neoplasia.

[25]  Lincoln D. Stein,et al.  Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells , 2012, Breast Cancer Research.

[26]  G. Coukos,et al.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales , 2011, Nature Reviews Immunology.

[27]  G. Fuller,et al.  Hypoxia Potentiates Glioma-Mediated Immunosuppression , 2011, PloS one.

[28]  J. Pober,et al.  Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. , 2007, The Journal of investigative dermatology.

[29]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.